Ryan Govender
Chief Executive Officer bij TREATT PLC
Vermogen: 674 $ op 29-02-2024
Profiel
Currently, Ryan Govender occupies the position of Chief Executive Officer, Secretary & Director at Treatt Plc.
Mr. Govender previously held the position of Chief Financial Officer at SPI Pharma, Inc.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
20-06-2023 | 973 ( 0.00% ) | 540 $ | 29-02-2024 | |
TREATT PLC
0.00% | 14-03-2024 | 27 ( 0.00% ) | 134 $ | 29-02-2024 |
Actieve functies van Ryan Govender
Bedrijven | Functie | Begin |
---|---|---|
TREATT PLC | Chief Executive Officer | 01-01-2024 |
Eerdere bekende functies van Ryan Govender
Bedrijven | Functie | Einde |
---|---|---|
SPI Pharma, Inc.
SPI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of The Garfield Weston Foundation, SPI Pharma, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Scott Thomson. | Director of Finance/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Treatt Plc | |
SPI Pharma, Inc.
SPI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of The Garfield Weston Foundation, SPI Pharma, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Scott Thomson. | Health Technology |